Dendreon Corp (DNDN)

0.06
0.00 6.02
NASDAQ : Health Care
Prev Close 0.06
Open 0.06
Day Low/High 0.06 / 0.06
52 Wk Low/High 0.04 / 3.46
Volume 1.37M
Avg Volume 5.11M
Exchange NASDAQ
Shares Outstanding 158.72M
Market Cap 20.16M
EPS -1.95
P/E Ratio N/A
Div & Yield N.A. (N.A)
July 11th Options Now Available For Dendreon (DNDN)

July 11th Options Now Available For Dendreon (DNDN)

Investors in Dendreon Corp saw new options become available today, for the July 11th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new July 11th contracts and identified the following put contract of particular interest.

July 3rd Options Now Available For Dendreon (DNDN)

July 3rd Options Now Available For Dendreon (DNDN)

Investors in Dendreon Corp saw new options begin trading today, for the July 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new July 3rd contracts and identified one put and one call contract of particular interest.

First Week of DNDN July 19th Options Trading

First Week of DNDN July 19th Options Trading

Investors in Dendreon Corp saw new options become available this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new July 19th contracts and identified one put and one call contract of particular interest.

Why Dendreon (DNDN) Stock Is Surging Today

Why Dendreon (DNDN) Stock Is Surging Today

Dendreon (DNDN) surged Tuesday after the company announced data from ProACT and IMPACT studies on PROVENGE, or sipuleucel-T.

Treatment With PROVENGE® (sipuleucel-T) Induces Antigen Spread Associated With Overall Survival Benefits In Advanced Prostate Cancer

Treatment With PROVENGE® (sipuleucel-T) Induces Antigen Spread Associated With Overall Survival Benefits In Advanced Prostate Cancer

May 20, 2014-Dendreon Corporation (NASDAQ: DNDN) today announced the presentation of data from the ProACT and IMPACT studies suggesting that PROVENGE ® (sipuleucel-T) elicits an immune response associated with an...

Dendreon Announces Presentation Of PROVENGE® (sipuleucel-T) And DN24-02 Immuno-Oncology Data At The 2014 ASCO Annual Meeting

Dendreon Announces Presentation Of PROVENGE® (sipuleucel-T) And DN24-02 Immuno-Oncology Data At The 2014 ASCO Annual Meeting

May 14, 2014 – Dendreon Corporation (NASDAQ: DNDN) announced today the presentation of two PROVENGE ® (sipuleucel-T) abstracts from the Phase II STAND study and the PROCEED registry, and one abstract...

Why Dendreon (DNDN) Stock Is Down Today

Why Dendreon (DNDN) Stock Is Down Today

Shares of Dendreon (DNDN) continue to decline after the biotechnology company reported 2014 first quarter results.

Interesting DNDN Put And Call Options For June 27th

Interesting DNDN Put And Call Options For June 27th

Investors in Dendreon Corp saw new options become available today, for the June 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new June 27th contracts and identified one put and one call contract of particular interest.

Dendreon Announces First Quarter 2014 Results

Dendreon Announces First Quarter 2014 Results

Dendreon Corporation (Nasdaq: DNDN) today reported results for the first quarter ended March 31, 2014.

Dendreon To Host Conference Call On May 8 To Announce First Quarter Financial Results

Dendreon To Host Conference Call On May 8 To Announce First Quarter Financial Results

Dendreon Corporation (Nasdaq:DNDN) today announced that management will host a conference call on Thursday, May 8, 2014 at 9:00 a.

First Week of DNDN June 21st Options Trading

First Week of DNDN June 21st Options Trading

Investors in Dendreon Corp saw new options begin trading this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new June 21st contracts and identified one put and one call contract of particular interest.

Immune Responses Enhanced And Sustained When PROVENGE® (sipuleucel-T) Is Given After Androgen Deprivation Therapy In Biochemically-Recurrent Prostate Cancer

Immune Responses Enhanced And Sustained When PROVENGE® (sipuleucel-T) Is Given After Androgen Deprivation Therapy In Biochemically-Recurrent Prostate Cancer

April 11, 2014 – Dendreon Corporation (NASDAQ: DNDN) today announced the presentation of preliminary data from a long-term analysis of the Phase II STAND study demonstrating that tumor-specific T-cell responses...

May 23rd Options Now Available For Dendreon (DNDN)

May 23rd Options Now Available For Dendreon (DNDN)

Investors in Dendreon Corp saw new options become available today, for the May 23rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new May 23rd contracts and identified the following call contract of particular interest.

May 9th Options Now Available For Dendreon (DNDN)

May 9th Options Now Available For Dendreon (DNDN)

Investors in Dendreon Corp saw new options begin trading today, for the May 9th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new May 9th contracts and identified the following call contract of particular interest.

Interesting DNDN Put And Call Options For November 22nd

Interesting DNDN Put And Call Options For November 22nd

Investors in Dendreon Corp saw new options become available this week, for the November 22nd expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Interesting DNDN Put And Call Options For May 2nd

Interesting DNDN Put And Call Options For May 2nd

Investors in Dendreon Corp saw new options begin trading today, for the May 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new May 2nd contracts and identified one put and one call contract of particular interest.

Interesting DNDN Put And Call Options For April 25th

Interesting DNDN Put And Call Options For April 25th

Investors in Dendreon Corp saw new options become available today, for the April 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new April 25th contracts and identified one put and one call contract of particular interest.

'Fast Money' Recap: China Syndrome

'Fast Money' Recap: China Syndrome

The trading panel discussed how to invest in and around China.

Today's Dead Cat Bounce Stock Is Dendreon (DNDN)

Today's Dead Cat Bounce Stock Is Dendreon (DNDN)

Trade-Ideas LLC identified Dendreon (DNDN) as a "dead cat bounce" (down big yesterday but up big today) candidate

Trade-Ideas: Dendreon (DNDN) Is Today's "Perilous Reversal" Stock

Trade-Ideas: Dendreon (DNDN) Is Today's "Perilous Reversal" Stock

Trade-Ideas LLC identified Dendreon (DNDN) as a "perilous reversal" (up big yesterday but down big today) candidate

'Fast Money' Recap: Ukraine Concerns

'Fast Money' Recap: Ukraine Concerns

The trading panel discussed how the crisis is affecting foreign markets and gold.

Why Dendreon Corporation (DNDN) Is Soaring Today

Why Dendreon Corporation (DNDN) Is Soaring Today

Dendreon Corporation (DNDN) soars after the biotechnology company reported fourth-quarter earnings that surpassed analysts' expectations. Dendreon reported a loss of 17 cents per share, which beat the Capital IQ consensus estimate of a loss of 24 cents a share by seven cents. Revenue also decreased 8.3% year over year to $74.8 million, which beat the consensus estimate of $72.89 million. The company also announced that it plans to make PROVENGE, its advanced prostate cancer treatment drug, available in Europe. The drug will first be available in the U.K. and Germany.

Trade-Ideas: Dendreon (DNDN) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas: Dendreon (DNDN) Is Today's Pre-Market Mover With Heavy Volume Stock

Trade-Ideas LLC identified Dendreon (DNDN) as a pre-market mover with heavy volume candidate

Dendreon Announces Plans To Make PROVENGE® Commercially Available In Europe

Dendreon Announces Plans To Make PROVENGE® Commercially Available In Europe

Dendreon Corporation today announced that it plans to make PROVENGE ® (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) available in Europe, beginning with Germany and the ...

Dendreon Announces Fourth Quarter And 2013 Year End Results

Dendreon Announces Fourth Quarter And 2013 Year End Results

Dendreon Corporation (NASDAQ:DNDN) today reported results for the fourth quarter and full year ended December 31, 2013.

The 10 Most Heavily Shorted Bio-Pharma Stocks

The 10 Most Heavily Shorted Bio-Pharma Stocks

The No. 1 stock on this list has more than half its float short.

Dendreon Announces Webcast Presentation At Cowen And Company Health Care Conference

Dendreon Announces Webcast Presentation At Cowen And Company Health Care Conference

Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the Cowen and Company 34 th Annual Health Care Conference in Boston, Massachusetts on Tuesday, March 4, 2014 at 11:20 a.

Interesting DNDN Put And Call Options For April 4th

Interesting DNDN Put And Call Options For April 4th

Investors in Dendreon Corp saw new options begin trading today, for the April 4th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new April 4th contracts and identified one put and one call contract of particular interest.

Dendreon To Host Conference Call On March 3 To Announce Fourth Quarter And Full Year 2013 Financial Results

Dendreon To Host Conference Call On March 3 To Announce Fourth Quarter And Full Year 2013 Financial Results

Dendreon Corporation (Nasdaq:DNDN) today announced that management will host a conference call on Monday, March 3, 2014 at 9:00 a.

Interesting DNDN Put And Call Options For March 28th

Interesting DNDN Put And Call Options For March 28th

Investors in Dendreon Corp saw new options become available today, for the March 28th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new March 28th contracts and identified one put and one call contract of particular interest.